Form 4: Guardant Health Director, Myrtle S. Potter, Reports Stock Transaction

Myrtle S. Potter, a director at Guardant Health, Inc., has reported the vesting of 68 restricted stock units.

Summary

• Myrtle S. Potter, a director of Guardant Health, Inc., reported a transaction involving restricted stock units.
• On January 15, 2025, 68 restricted stock units vested, converting into 68 shares of common stock.
• The transaction was a result of the vesting schedule of the restricted stock units, which began on October 15, 2022.
• Following the transaction, Ms. Potter directly owns 616 shares of common stock.

Sentiment

Score: 5

Explanation: This is a routine filing of a stock transaction, and does not indicate any positive or negative sentiment.

Industry Context

This is a routine filing related to insider transactions, which is common for publicly traded companies. It provides transparency into the stock ownership of company directors.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
• The vesting schedule of restricted stock units is a common method of compensation for directors and employees in the technology and biotech industries.
• The number of shares involved in this transaction is relatively small compared to the overall market capitalization of Guardant Health, which is typical for individual director transactions.

Stakeholder Impact

• This transaction has a minimal impact on shareholders as it is a small number of shares compared to the total outstanding shares.
• The transaction is part of the compensation package for a director, which is a standard practice.

Key Dates

Keywords

Guardant Health, Myrtle S. Potter, stock transaction, restricted stock units, insider trading, Form 4, vesting